Alyssa Tippens
About Alyssa Tippens
Alyssa Tippens is a Field Medical Scientist specializing in Solid Tumor Immuno-Oncology at Bristol-Myers Squibb in Denver, Colorado, with extensive experience in scientific strategy and medical writing.
Title and Current Role
Alyssa Tippens is a Field Medical Scientist specializing in Solid Tumor Immuno-Oncology. She is currently employed at Bristol-Myers Squibb in Denver, Colorado, United States. In this role, Alyssa focuses on advancing medical knowledge and contributing to the development of innovative treatments in the field of oncology.
Previous Roles and Experience
Alyssa Tippens has held various positions at Bristol-Myers Squibb, including serving as the Publication Lead for Immuno-Oncology, Lung, and Biomarkers from 2015 to 2017 in New York, New York. Prior to this, she was the Associate Director of Scientific Strategy at Envision Communications from 2012 to 2015. Alyssa also worked as a Senior Medical Writer at Apothecom: A Medistrava Company in 2011 and as a Medical Writer at Scientific Connexions in 2009. Her early career includes roles at MedErgy HealthGroup as both a Senior Medical Writer and Medical Writer from 2007 to 2011.
Education and Academic Background
Alyssa Tippens earned her Doctor of Philosophy from Emory University School of Medicine, where she studied from 2002 to 2007. Prior to that, she received a Bachelor of Science degree from Old Dominion University, studying there from 1996 to 1998. Alyssa completed her high school education at York High School, graduating in 1996.
Early Career and Analytical Background
Earlier in her career, Alyssa Tippens worked as an Analytical Chemist and Environmental Impacts Analyst at Interface from 1999 to 2002. This foundational experience in scientific analysis and environmental impacts contributed to her extensive expertise in scientific research and medical communications.
Expertise in Solid Tumor Immuno-Oncology
Alyssa Tippens has been working in the field of Solid Tumor Immuno-Oncology for over six years. She has substantial experience in scientific strategy and medical writing, which has enabled her to transition into more strategic and scientific leadership roles. Her career reflects a blend of hands-on research and high-level strategic planning, particularly in oncology.